Millennium Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Millennium Management’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,705	Closed	-$18.2K	–	6791
2023 Q4	$18.2K	Sell	2,705 -6,271	-70%	-$55.1K	﹤0.01%	5648
2023 Q3	$82.1K	Sell	8,976 -1,351	-13%	-$27.2K	﹤0.01%	5383
2023 Q2	$218K	Buy	10,327 +9,867	+2,145%	+$304K	﹤0.01%	5071
2023 Q1	$12K	Sell	460 -25,111	-98%	-$1.17M	﹤0.01%	5991
2022 Q4	$905K	Buy	+25,571	New	+$3.07M	﹤0.01%	4265
2021 Q4	–	Sell	-577	Closed	-$116K	–	7537
2021 Q3	$116K	Buy	+577	New	+$137K	﹤0.01%	6371
2021 Q2	–	Sell	-4,496	Closed	-$1.19M	–	7274
2021 Q1	$1.19M	Sell	4,496 -622	-12%	-$196K	﹤0.01%	4038
2020 Q4	$1.89M	Buy	+5,118	New	+$1.47M	﹤0.01%	3285
2020 Q2	–	Sell	-429	Closed	-$88K	–	4714
2020 Q1	$88K	Sell	429 -328	-43%	-$105K	﹤0.01%	3574
2019 Q4	$339K	Buy	+757	New	+$269K	﹤0.01%	3599
2019 Q2	–	Sell	-7,081	Closed	-$2.97M	–	4578
2019 Q1	$2.97M	Buy	7,081 +6,245	+747%	+$2.51M	﹤0.01%	2128
2018 Q4	$255K	Buy	+836	New	+$270K	﹤0.01%	3295
2018 Q3	–	Sell	-2,379	Closed	-$871K	–	4364
2018 Q2	$871K	Buy	+2,379	New	+$847K	﹤0.01%	2914
2018 Q1	–	Sell	-1,242	Closed	-$520K	–	4184
2017 Q4	$520K	Sell	1,242 -425	-25%	-$152K	﹤0.01%	3076
2017 Q3	$550K	Buy	1,667 +126	+8%	+$34.3K	﹤0.01%	2799
2017 Q2	$365K	Buy	+1,541	New	+$350K	﹤0.01%	2959
2016 Q1	–	Sell	-156	Closed	-$103K	–	3755
2015 Q4	$103K	Buy	+156	New	+$88.3K	﹤0.01%	3241
2015 Q2	–	Sell	-1,971	Closed	-$16.8M	–	3960
2015 Q1	$16.8M	Buy	1,971 +1,874	+1,932%	+$16.4M	0.03%	753
2014 Q4	$852K	Buy	+97	New	+$563K	﹤0.01%	2609
2014 Q3	–	Sell	-27	Closed	-$195K	–	4079
2014 Q2	$195K	Buy	+27	New	+$135K	﹤0.01%	3136

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

AWP

Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Millennium Management's EIGR Position: Q1 2024 in Review

Millennium Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 2,705 shares — an estimated $18.2K sold.

Millennium Management first reported a position in EIGR in Q2 2014 and held it in 20 quarters. The position peaked at $16.8M in Q1 2015. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

Millennium Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 2,705 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $18.2K.
Millennium Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2014 and held it in 20 quarters.
Millennium Management's Eiger BioPharmaceuticals, Inc. position peaked at $16.8M in Q1 2015.
24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.